Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2401 USD | -1.50% | +15.99% | -68.28% |
May. 06 | PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index | CI |
May. 01 | PaxMedica, Inc.(NasdaqCM:PXMD) dropped from NASDAQ Composite Index | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.79M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.22
x | P/E ratio 2025 * |
-
| Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.4% |
1 day | -1.50% | ||
1 week | +15.99% | ||
Current month | -67.77% | ||
1 month | -68.54% | ||
3 months | -63.57% | ||
6 months | -86.28% | ||
Current year | -68.28% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Weisman
CEO | Chief Executive Officer | 64 | 20-03-03 |
Stephen Sheldon
DFI | Director of Finance/CFO | 44 | 22-06-30 |
David Hough
CTO | Chief Tech/Sci/R&D Officer | 67 | 23-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 22-09-30 | |
Howard Weisman
CEO | Chief Executive Officer | 64 | 20-03-03 |
Zachary Rome
BRD | Director/Board Member | 40 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.2401 | -1.50% | 86,563 |
24-05-16 | 0.2438 | -7.50% | 56,804 |
24-05-15 | 0.2635 | +27.29% | 131,786 |
24-05-14 | 0.207 | -9.53% | 66,710 |
24-05-13 | 0.2288 | +10.53% | 91,588 |
Delayed Quote OTC Markets, May 17, 2024 at 03:55 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.28% | 1.79M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- PXMD Stock